PCM
AMGN icon

Pointe Capital Management’s Amgen AMGN Stock Holding History

Pointe Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-90
Closed -$21.8K – 159
2023
Q1 		$21.8K Buy
+90
New +$22.1K 0.02% 273
2017
Q4 		– Sell
-1,400
Closed -$261K – 149
2017
Q3 		$261K Hold
1,400
– – 0.19% 134
2017
Q2 		$241K Buy
+1,400
New +$228K 0.17% 146

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pointe Capital Management's AMGN Position: Q2 2023 in Review

Pointe Capital Management sold out of Amgen (AMGN) in Q2 2023, closing a stake of 90 shares — an estimated $21.8K sold.

Pointe Capital Management first reported a position in AMGN in Q2 2017 and held it in 3 quarters. The position peaked at $261K in Q3 2017. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Pointe Capital Management reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Pointe Capital Management sold 90 Amgen shares in Q2 2023, an estimated $21.8K.
  • Pointe Capital Management first reported a position in Amgen in Q2 2017 and held it in 3 quarters.
  • Pointe Capital Management's Amgen position peaked at $261K in Q3 2017.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Pointe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.